TB-500

Also known as: Thymosin Beta-4 Fragment

Healing & RecoveryPRECLINICAL

Clinical Status

Preclinical — No human clinical trials. FDA Category 2. WADA prohibited.

Mechanism of Action

Derived from the active region of Thymosin Beta-4. Promotes cell migration by binding to and sequestering actin. Upregulates actin expression, promotes angiogenesis, reduces inflammation, and facilitates wound healing.

Dosing Defaults

Dose

2-2.5 mg

Frequency

2x weekly

Administration

Subcutaneous or intramuscular injection

Timing

Morning or evening

Food

with or without

Duration

4-6 weeks loading, then maintenance

Dose range: 2-10 mg per week during loading phase

Long half-life makes timing flexible. Consistency matters more than specific time.

Side Effects

•Injection site reactions
•Headache
•Fatigue
•Nausea
•May trigger histamine release

Contraindications & Warnings

⚠Active cancer or cancer history

•Not medical advice
•FDA Category 2
•WADA prohibited

Compare

Compare TB-500 with another peptide side-by-side.

Calculate Dose

Use the reconstitution calculator to prepare your TB-500 dose.

Open Calculator

Related Healing & Recovery Peptides

BPC-157

PRECLINICAL

Healing & Recovery

Synthetic peptide derived from human gastric juice. Known for tissue healing properties.

Pentadecapeptide

PRECLINICAL

Healing & Recovery

Research peptide studied for wound healing and tissue regeneration.

Thymosin Beta-4

PHASE 2

Healing & Recovery

Full-length thymosin protein for wound healing and cardiac tissue repair.

GHK

PHASE 2

Healing & Recovery

Naturally occurring tripeptide for tissue remodeling without the copper component.

This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.